• News
  • SAN DIEGO
  • BioTech

Avelas Biosciences completes new round of financing

Avelas Biosciences has announced the closing of $6.85 million in Series B financing that will go toward funding the advancement of its fluorescent peptide designed to illuminate cancer cells.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!